200 related articles for article (PubMed ID: 33646556)
1. Identification of circulating biomarkers for differentiating patients with papillary thyroid cancers from benign thyroid tumors.
Wu SC; Chi SY; Rau CS; Kuo PJ; Huang LH; Wu YC; Wu CJ; Lin HP; Hsieh CH
J Endocrinol Invest; 2021 Nov; 44(11):2375-2386. PubMed ID: 33646556
[TBL] [Abstract][Full Text] [Related]
2. Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting 131I Uptake and Mortality in Papillary Thyroid Cancer Patients with Lung Metastases.
Qiu ZL; Shen CT; Sun ZK; Wei WJ; Zhang XY; Song HJ; Luo QY
Cell Physiol Biochem; 2016; 40(6):1377-1390. PubMed ID: 27997908
[TBL] [Abstract][Full Text] [Related]
3. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z
Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760
[TBL] [Abstract][Full Text] [Related]
4. Significance of LINC02082 and LOC105369812 in differentiating papillary thyroid cancer from benign nodules.
Xu J; Liu W; Li R; Wang Y
Medicine (Baltimore); 2023 Nov; 102(44):e35542. PubMed ID: 37932992
[TBL] [Abstract][Full Text] [Related]
5. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules.
Zhang A; Wang C; Lu H; Chen X; Ba Y; Zhang C; Zhang CY
Dis Markers; 2019; 2019():3717683. PubMed ID: 31636734
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
Li Q; Li H; Zhang L; Zhang C; Yan W; Wang C
Oncotarget; 2017 Jul; 8(28):46136-46144. PubMed ID: 28545026
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
[TBL] [Abstract][Full Text] [Related]
8. Expression profile of long noncoding RNAs in human papillary thyroid carcinoma.
Cao Y; Shi C; Li J; Liang Y; Qiu J; Yuan L; Yong Z; Zhang DX; Shi GQ
Neoplasma; 2019 Mar; 66(2):245-251. PubMed ID: 30569720
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential LncRNAs as papillary thyroid carcinoma biomarkers based on integrated bioinformatics analysis using TCGA and RNA sequencing data.
Feng JL; Zheng WJ; Xu L; Zhou QY; Chen J
Sci Rep; 2023 Mar; 13(1):4350. PubMed ID: 36928327
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA TCONS_00000200 as a non-invasive biomarker in patients with intracranial aneurysm.
Wu C; Song H; Wang Y; Gao L; Cai Y; Cheng Q; Chen Y; Zheng Z; Liao Y; Lin J; Xie B; Cai W; Li S; Liao L; Yan X
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31710082
[TBL] [Abstract][Full Text] [Related]
11. Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer.
Wang M; Zhang Z; Pan D; Xin Z; Bu F; Zhang Y; Tian Q; Feng X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212174
[TBL] [Abstract][Full Text] [Related]
12. A panel consisting of three novel circulating lncRNAs, is it a predictive tool for gastric cancer?
Liu J; Wang J; Song Y; Ma B; Luo J; Ni Z; Gao P; Sun J; Zhao J; Chen X; Wang Z
J Cell Mol Med; 2018 Jul; 22(7):3605-3613. PubMed ID: 29700972
[TBL] [Abstract][Full Text] [Related]
13. Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer.
Duan W; Du L; Jiang X; Wang R; Yan S; Xie Y; Yan K; Wang Q; Wang L; Zhang X; Pan H; Yang Y; Wang C
Oncotarget; 2016 Nov; 7(48):78850-78858. PubMed ID: 27793008
[TBL] [Abstract][Full Text] [Related]
14. Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis.
Cai WY; Chen X; Chen LP; Li Q; Du XJ; Zhou YY
J Cell Biochem; 2018 Nov; 119(10):8249-8259. PubMed ID: 29968931
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic signature with seven LncRNAs for papillary thyroid carcinoma.
Guo C; Li H; Pan N; Xu S; Zeng Q; Zhou B; Wang J
Adv Med Sci; 2022 Mar; 67(1):103-113. PubMed ID: 35121283
[TBL] [Abstract][Full Text] [Related]
16. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
[TBL] [Abstract][Full Text] [Related]
17. Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.
Wang Q; Yang H; Wu L; Yao J; Meng X; Jiang H; Xiao C; Wu F
Thyroid; 2016 Dec; 26(12):1719-1732. PubMed ID: 27758138
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of long noncoding RNA MALAT1 in papillary thyroid cancer and its diagnostic value.
Liu J; Dong H; Yang Y; Qian Y; Liu J; Li Z; Guan H; Chen Z; Li C; Zhang K; Zhang Q; Cao W; Lv J
Future Oncol; 2018 Dec; 14(29):3015-3022. PubMed ID: 29987950
[TBL] [Abstract][Full Text] [Related]
19. Identification of Differentially Expressed Plasma lncRNAs As Potential Biomarkers for Breast Cancer.
Wang M; Liu H; Wu W; Zhao J; Song G; Chen X; Wang R; Shao C; Li J; Wang H; Wang Q; Feng X
Clin Breast Cancer; 2022 Feb; 22(2):e135-e141. PubMed ID: 34119428
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis of long noncoding RNA expression profile in papillary thyroid carcinoma.
Lan X; Zhang H; Wang Z; Dong W; Sun W; Shao L; Zhang T; Zhang D
Gene; 2015 Sep; 569(1):109-17. PubMed ID: 26003293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
